CORONA Remedies Limited (NSEI: CORONA)
Health Care · Pharmaceuticals · IN
Rs2,024.00
-0.27% today · +40.7% 1Y
CORONA Remedies Limited (NSEI: CORONA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.28B.
Over the last twelve months the share price has gained 40.7%, trading between 1.34K and 2.29K.
Tweenvest scores CORONA Remedies Limited across four factors: quality 85/100, value 20/100, growth 75/100, dividend 91/100. Its strongest factor is dividend.
CORONA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.28B
- Revenue (TTM)
- $156.43M
- P/E
- 62.18
- EPS
- 32.55
- Dividend yield
- 0.49%
- Beta (5Y)
- —
- 52-week high
- Rs2,292.40
- 52-week low
- Rs1,336.60
- Avg volume (3M)
- —
- Shares outstanding
- 61.16M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Xiamen Kingdomway Group CompanySZSE: 002626 | $1.43B | CN¥15.89 | -1.49% |
| Zhejiang Jolly Pharmaceutical Co.,LTDSZSE: 300181 | $1.38B | CN¥13.25 | +0.30% |
| Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.SHSE: 688076 | $1.37B | CN¥29.01 | +0.28% |
| Shandong Lukang Pharmaceutical Co.,Ltd.SHSE: 600789 | $1.29B | CN¥8.28 | +5.48% |
| Celltrion Pharm, Inc.KOSDAQ: A068760 | $1.28B | ₩38,800.00 | -3.24% |
| Zhejiang Xianju Pharmaceutical Co., Ltd.SZSE: 002332 | $1.27B | CN¥8.76 | +1.39% |
| Shandong Xinhua Pharmaceutical Company LimitedSEHK: 719 | $1.25B | HK$5.69 | -1.90% |
| HARBIN GLORIA PHARMACEUTICALS Co., LTDSZSE: 002437 | $1.23B | CN¥3.69 | +1.10% |
Figures last refreshed Oct 11, 2026.